Left ventricular structure and function in children infected with Human Immunodeficiency Virus: The Prospective P2C2 HIV Multicenter study

Circulation

Volumn 97, Issue 13, 1998, Pages 1246-1256

  Lipshultz, Steven E ^a,b,c,i   Easley, Kirk A ^d   Orav, E John ^e   Kaplan, Samuel ^f   Starc, Thomas J ^g   Bricker, J Timothy ^h   Lai, Wyman W ^f   Moodie, Douglas S ^d   McIntosh, Kenneth ^a,b   Schluchter, Mark D ^d   Colan, Steven D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g The New York Presbyterian Hospital   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

AIDS; Cardiomyopathy; Heart failure; HIV; Pediatrics

Indexed keywords

ZIDOVUDINE;

ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0032492759     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.13.1246     Document Type: Article

References (37)

1. Lipshultz S, Chanock S, Sanders SP, Colan SD, McIntosh K. Cardiac manifestations of human immunodeficiency infection in infants and children. Am J Cardiol. 1989;63:1489-1497.
2. Lipshultz SE, Orav EJ, Sanders SP, Hale AR, McIntosh K, Colan SD. Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med. 1992;327:1260-1265.
3. Tovo PA, de Martino M, Gabiano C, Cappello N, D'Elia R, Loy A. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet. 1992;339:1249-1253.
4. Luginbuhl LM, Orav EJ, McIntosh K, Lipshultz SE. Cardiac morbidity and related mortality in children with HIV infection. JAMA. 1993;269:2869-2875.
5. Turner BJ, Denison M, Eppes SC, Houchens R, Fanning T, Markson LE. Survival experience of 789 children with the acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1993;12:310-320.
6. Grenier MA, Karr SS, Rakusan TA, Martin GR. Cardiac disease in children with HIV: relationship of cardiac disease to HIV symptomatology. Pediatr AIDS HIV Infect. 1994;5:174-179.
7. Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet. 1994;343:191-195.
8. Lipshultz SE, Orav EJ, Sanders SP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation. 1995;92:2220-2225.
9. Al-Attar I, Orav EJ, Exil V, Lipshultz SE. Predictors of cardiac morbidity and related mortality in children with the acquired immunodeficiency syndrome. Pediatr Res. 1995;37:169A. Abstract.
10. 2 study. Pediatr Res. 1995;37:189A. Abstract.
11. Domanski MJ, Sloas MM, Follmann DA, Scalise PP, Tucker EE, Egan D, Pizzo PA. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr. 1995;127:137-146.
12. Lindegren ML, Caldwell B, Oxtoby M. Paediatric HIV infection in the U S A. In: Mok JYQ, Newell M-L, eds. HIV Infection in Children: A Guide to Practical Management. New York, NY: Cambridge University Press; 1995:21-51.
13. Lipshultz SE, Bancroft EA, Boller A-M. Cardiovascular manifestations of HIV infection in children. In: Bricker JT, Garson A Jr, Físher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Baltimore, Md: Williams & Wilkins; 1997.
14. Miller TL, Orav EJ, Colan SD, Lipshultz SE. Nutritional status and cardiac mass and function in children infected with the human immunodeficiency virus. Am J Clin Nutr. 1997;66:660-664.
15. 2 HIV Study Group. Postmortem cardiomegaly correlates with premortem measurements of left ventricular size in malnourished HIV-infected children. Third Conference on Retroviruses and Opportunístíc Infections. Washington DC, January 28-Februaty 1, 1996 (session 67). Abstract 431.
16. 2 Study. Third Conference on Retroviruses and Opportunistic Infections. Washington DC, January 28-February 1, 1996 (session 65). Abstract 415.
17. Lobato MN, Caldwell B, Ng P, Oxtoby MJ. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. J Pediatr. 1995;126:710-715.
18. 2 study. 2nd International Conference on Retroviruses. Proceedings, Washington DC, January 29-February 2, 1995;90. Abstract 193.
19. 2 HIV) infection study: design and methods. J Clin Epidemiol. 1996;49:1285-1294.
20. Centers for Disease Control and Prevention. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep. 1987;36:225-236.
21. Mofenson LM, Bethel J, Moye J, Flyer P, Mugent R, for the National Institute of Child Health, and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Effect of intravenous immuno- globulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. J Acquir Immune Defic Syndr. 1993;6:1103-1113.
22. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol. 1992;19:619-629.
23. Devereux RB, Alonso DR, Lutas EM. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
24. Shah A, Laird N, Schoenfeld D. A random effects model for multiple characteristics with possibly missing data. J Am Stat Assoc. 1997;92:775-779.
25. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordana A, Guida R. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 1996;334:809-814.
26. Freeman R, Roberts MS, Friedman LS. Autonomic function and human immunodeficiency virus infection. Neurology. 1990;40:575-580.
27. Van Vliet PD, Burchell HB, Titus JL. Myocarditis associated with pheochromocytoma. N Engl J Med. 1966;274:1102-1108.
28. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, U. S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
29. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
30. Lipshultz SE, Fox CH, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, Winter HS. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol. 1990;66:246-250.
31. Anderson DW, Virmani R, Reilly JM. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol. 1988;11:792-799.
32. Aldhous MC, Raab GM, Mok JYQ, Doherty KV, Bird AG, Froebel KS. CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr AIDS HIV Infect. 1996;7:20-30.
33. Barnhart HX, Caldwell MB, Thomas P, Mascola L, Ortiz I, Hsu H-W. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics. 1996;97:710-716.
34. Scientific Advisory Committee on Surrogate Markers of HIV. Consensus statement. J Acquir Immun Defic Syndr Hum Retrovirol. 1995;10(suppl 2):S114-S116.
35. Choi S, Lagakos SW, Schooley TT, Volberding PA. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med. 1993;118:674-680.
36. Concorde Coordinating Committee. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet. 1994;343:871-881.
37. Al-Attar I, Orav EJ, Exil V, McIntosh K, Lipshultz SE. Survival patterns of pediatric patients with the acquired immunodeficiency syndrome. Pediatr Res. 1995:37:169A. Abstract.